SARS-CoV-2 Delta Variant Pseudovirus

Spike glycoprotein Receptor-binding domain, S glycoprotein, Spike protein, Delta variant spike, Delta variant pseudovirus, Delta, pseudovirus reporter, reporter virus particle

1.0 mL (0.5mL X 2 vials) for two 96-well plates

Protocol: click here to download

1. Require BSL-2 or higher working environment
2. 5 ?L per application (96-well plate) with at least 0.3 X 10⁶ RLU / well.
3. Avoid freezing and thawing cycle to ensure the titer of the pseudovirus.
4. This product is for Research Use only
5. Neutralization assay protocol is available

SARS-CoV-2 Delta Pseudovirus uses HIV pseudotyped with SARS-CoV-2 spike protein and firefly luciferase reporter. This pseudovirus effectively infects human ACE2 overexpressing cells and can be used to screen for inhibitors of Spike-ACE2 interaction, determine neutralizing antibody titers, and is a valuable tool for COVID-19 vaccine development as well.

DMEM/10% FBS

43740568

Surface glycoprotein

S

Severe acute respiratory syndrome coronavirus 2

Liquid

QHD43416

1791269090

Delta Variant Spike Met 1 - Cys 1252 (T19R, T95I, G142D, EF156-157del, R158G, L452R, T478K, D614G, P681R, D950N)

Infectious Disease, COVID-19

HEK293 cells

P0DTC1